TC
Congress trade
Sen. Thomas Carper (D-DE) bought $1K-$15K of Abbott Laboratories (NYSE) (ABT) stock
Thomas Carper, U.S. Senator (D-DE), disclosed a purchase of Abbott Laboratories (NYSE) (ABT) stock worth $1K-$15K in a STOCK Act filing on Mar 3, 2015.
The trade happened on Feb 12, 2015, 19 days before it was made public.
ABT has moved +115.6% since the trade date, from $45.22 to $97.50 (Oct 2, 2026 close).
- Traded
- Feb 12, 2015
- Disclosed
- Mar 3, 2015
- Filing delay
- 19 days
- Price since
- +115.6%
- Source
- STOCK Act disclosure
Other trades in this disclosure (7)
More ABT insider and Congress trades
From a public STOCK Act disclosure, linked above. Not investment advice, and not a recommendation to buy or sell.